This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Preparing for Phase 3 data on Transcon PTH in Hypoparathyroidism expected in February 2022

Ticker(s): ASND

Who's the expert?

Institution: Children's Hospital of Philadelphia

  • Chief Emeritus of Endocrinology and Diabetes and Director of the Center for Bone Health at The Children’s Hospital of Philadelphia &  Professor Emeritus of Pediatrics and Medicine at the University of Pennsylvania Perelman School of Medicine. 
  • Research interests focus on the genetic basis of endocrine signaling defects; his approach is to apply molecular and genetic tools to analyze the basis of altered hormone action, particularly in G protein-coupled signal transduction systems that affect growth and development. 
  • Identified the molecular basis of several inherited disorders of mineral metabolism, including familial hypoparathyroidism, pseudohypoparathyroidism, and the McCune Albright syndrome. 

Interview Goal
Reviewing the public data to date for Transcon PTH and expectations / potential for success in the current Phase 3 trial.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.